These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1947759)

  • 41. 28. Meeting of Nordic ophthalmologists. Proceedings. Trondheim, Norway, 13-16, 1987.
    Acta Ophthalmol Suppl (1985); 1987; 182():1-175. PubMed ID: 2837041
    [No Abstract]   [Full Text] [Related]  

  • 42. Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers.
    Chan KC; Lo YM
    Br J Cancer; 2007 Mar; 96(5):681-5. PubMed ID: 17311021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [IV Conference on the Determination of Immunohistochemical and Morphometric Tumor Markers for Breast Neoplasms. Proceedings. Milano, 6-7 June 1991].
    Pathologica; 1992; 84(1094):1-100. PubMed ID: 1363756
    [No Abstract]   [Full Text] [Related]  

  • 44. Performance of the mucinous-like carcinoma-associated antigen in serous effusions.
    Cappellari A; Bagarella M; Olivati S; Corradi G
    Oncology; 1992; 49(5):354-7. PubMed ID: 1528570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum tumor markers: diagnostic or para-diagnostic.
    Mehdi I
    J Pak Med Assoc; 1998 May; 48(5):118-20. PubMed ID: 9813969
    [No Abstract]   [Full Text] [Related]  

  • 46. Abstracts of the 12th International Hamburg Symposium on Tumor Markers. November 30-December 2, 2003, Hamburg, Germany.
    Anticancer Res; 2003; 23(6B):4485-548. PubMed ID: 14979284
    [No Abstract]   [Full Text] [Related]  

  • 47. Emerging molecular markers in oncology: focused therapy, indicators of response, chemoprevention. Proceedings of a workshop. Rovigo, Italy. September 20, 2002.
    Int J Biol Markers; 2003; 18(1):34-86. PubMed ID: 14692414
    [No Abstract]   [Full Text] [Related]  

  • 48. Increased plasma concentrations of tumour markers in the absence of neoplasia.
    Trapé J; Filella X; Alsina-Donadeu M; Juan-Pereira L; Bosch-Ferrer Á; Rigo-Bonnin R;
    Clin Chem Lab Med; 2011 Oct; 49(10):1605-20. PubMed ID: 21892908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibody biomarkers in the detection of cancer.
    Cho-Chung YS
    Biochim Biophys Acta; 2006 Jun; 1762(6):587-91. PubMed ID: 16730166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diet and cancer. Markers, prevention, and treatment. October 29-30, 1992, McLean, Virginia. Proceedings.
    Adv Exp Med Biol; 1994; 354():1-248. PubMed ID: 8067278
    [No Abstract]   [Full Text] [Related]  

  • 51. Tumour markers.
    Pandha HS; Waxman J; Sikora K
    Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):297-303. PubMed ID: 8032568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of markers in fine tuning of chemotherapy.
    Ward AM
    Cancer Treat Rev; 1987 Dec; 14(3-4):401-5. PubMed ID: 3440258
    [No Abstract]   [Full Text] [Related]  

  • 53. Research in Gene Diagnostics of Cancer Disease. Proceedings of a meeting. Munster, Germany, October 24-28, 1994.
    Gene; 1995 Jun; 159(1):1-135. PubMed ID: 7607563
    [No Abstract]   [Full Text] [Related]  

  • 54. Prognostic factors in pulmonary metastasectomy: spotlight on molecular and radiological markers.
    Schweiger T; Lang G; Klepetko W; Hoetzenecker K
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):408-16. PubMed ID: 23729747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumour markers: their use and misuse by clinicians.
    McGinley PJ; Kilpatrick ES
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):643-7. PubMed ID: 14629802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Criteria of organ specificity of a tumor].
    Zolotarevskiĭ VB; Kogan EA
    Arkh Patol; 1984; 46(2):90-6. PubMed ID: 6370208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tumour markers of pancreatic cancer (tumour associated antigens)].
    Groblewska M; Mroczko B; Szmitkowski M
    Pol Arch Med Wewn; 2005 Jun; 113(6):585-93. PubMed ID: 16454450
    [No Abstract]   [Full Text] [Related]  

  • 58. [Precision medicine from experimental to clinical applications in oncology].
    Normanno N
    Recenti Prog Med; 2015 Dec; 106(12):597-600. PubMed ID: 26780068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Markers in urology. Proceedings of the 2nd Mediterranean Congress of Urology. Rome, Italy, July 3-6, 1991.
    Eur Urol; 1992; 21 Suppl 1():1-116. PubMed ID: 1358616
    [No Abstract]   [Full Text] [Related]  

  • 60. [Second International Expert Meeting of the German Foundation for Cancer Research, "Current trends in cancer research." Critical review of tumour markers in diagnosis and surveillance].
    von Kleist S; Wagener C; Breuer H
    Onkologie; 1980 Dec; 3(6):310-5. PubMed ID: 6164027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.